Sagamihara, Japan

Shin Egawa

This inventor holds 1 USPTO granted patent. Top assignee: Tosoh Corporation. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shin Egawa. Retrieved from https://idiyas.com/inventor/shin-egawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Shin Egawa

Introduction

Shin Egawa is a notable inventor based in Sagamihara, Japan. He has made significant contributions to the field of cancer detection and treatment. His work focuses on innovative methods that leverage the detection of specific viral antigens to diagnose and potentially treat cancer.

Latest Patents

Shin Egawa holds a patent for a method and composition for detecting cancer by means of detection of Epstein-Barr virus nuclear antigen 2 coactivator P100. This invention relates to a method for diagnosing cancer and a detection reagent based on the detection of Epstein-Barr virus nuclear antigen 2 (EBNA2) coactivator p100 contained in a specimen. Additionally, it outlines a method for treating cancer by controlling the expression of the EBNA2 coactivator p100 protein or a gene thereof. He has 1 patent to his name.

Career Highlights

Shin Egawa is associated with Tosoh Corporation, where he continues to contribute to advancements in medical technology. His work is pivotal in enhancing the accuracy of cancer diagnostics, which can lead to better patient outcomes.

Collaborations

He has collaborated with notable colleagues such as Hiroyuki Takahashi and Hidetoshi Kuruma, further enriching his research and development efforts.

Conclusion

Shin Egawa's innovative work in cancer detection and treatment exemplifies the impact of scientific research on healthcare. His contributions are vital in the ongoing fight against cancer, showcasing the importance of innovation in medical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…